Dietary luteolin intake during oxaliplatin-based chemotherapy would at least not be deleterious to the anticancer efficacy of oxaliplatin but, rather, could be additively working in colorectal cancer, carrying malfunctioning p53 protein by augmenting cancer cell growth inhibition. This evidence concerns the gene TP53 and colorectal cancer.